Skip to contentG
GE HealthCare Technologies Inc.
G
GEHCGE HealthCare Technologies Inc. Q3 2025 · 10-Q
Revenue$5.14B$5.14B+5.8% vs Q3 2024 Net Income$446.00M$446.00M−5.1% vs Q3 2024 EPS Diluted$0.98$0.98−3.9% vs Q3 2024 Gross Profit$1,990,000,000−1.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GE HealthCare Technologies Inc. · CIK 1932393 · Engraved from SEC EDGAR
Operating Cash Flowderived$593,000,000−20.1% Free Cash Flowderived$483,000,000−25.9% Margins · derivedGross margin38.7%−3.0 pt vs Q3 2024
Operating margin12.7%−1.2 pt vs Q3 2024
Net margin8.7%−1.0 pt vs Q3 2024
ended Sep 30, 2025 · filed Oct 29, 2025 · 29 d after period end